Profit by knowlytics
Sotefin Bharat is set to debut on the BSE SME platform on July 23, with grey market premium (GMP) trends indicating a largely flat listing. Despite subdued GMP, the Rs 89.76-crore IPO was subscribed 3.78 times overall, backed by healthy participation across investor categories. The company plans to use the IPO proceeds to expand manufacturing…
Indian stock markets extended losses for a fourth session on Thursday. Sensex and Nifty declined as oil prices surged following US strikes on Iran. Broader market indices also saw a downward trend, with several sectors opening in the red. Escalating tensions pushed Brent crude futures above ninety-six dollars per barrel. This situation presents opportunities for…
IndusInd Bank shares fell despite reporting a 72% year-on-year jump in Q1 FY27 net profit to Rs 1,037 crore and brokerages raising target prices. Investors remained cautious as net interest income stayed largely flat at Rs 4,685 crore. The lender’s profitability was supported by an improvement in net interest margin to 3.57%.
Shares of Eternal climbed 3% after its Q1FY27 earnings, with brokerages reaffirming bullish views on the stock. JPMorgan, CLSA, Jefferies, Nomura, Motilal Oswal and Emkay retained positive ratings, citing accelerating growth in food delivery and Blinkit, improving quick commerce profitability, stronger margin guidance and management’s confidence that competitive intensity has become more predictable.
Dr Reddy’s shares plunged 9% on Thursday after the drugmaker reported a weak Q1 FY27 performance, with net profit tumbling 69% year-on-year to Rs 443 crore and revenue declining 6% to Rs 8,071 crore. Earnings were hit by a Rs 240 crore semaglutide API-related impact, including inventory provisions, while higher solvent and freight costs due…
11 smallcaps have at least doubled in six months, led by Sterlite Technologies’ 451% jump, as FIIs raised stakes across the March and June 2026 quarters. The parallel rise signals selective conviction, but analysts warn the sharp rerating leaves little room for earnings misses.
Infosys is expected to post double-digit growth in revenue and profit for Q1FY27, aided by seasonal factors and acquisitions. However, brokerages remain divided on whether the IT major will raise or trim its FY27 revenue growth guidance amid macro uncertainty, weak discretionary spending and AI-led pricing pressure.
IBM reduced its annual revenue growth forecast on Wednesday. The company also missed profit and revenue expectations for the second quarter. This shift occurred as corporate spending moved towards AI data-center gear. IBM’s Z mainframe revenue slumped significantly, impacting overall infrastructure performance. Executives reassured shareholders about long-term mainframe demand despite current challenges.
South Korea’s Kospi surged 4% on Thursday, extending gains for a third straight session, as stronger-than-expected economic growth and robust AI spending plans from US tech giants boosted chip stocks. Samsung Electronics and SK Hynix climbed up to 6%, driving the benchmark higher after GDP expanded 0.6% in the April-June quarter, beating forecasts.
The IPO is a fresh issue of 1.31 crore equity shares, aiming to raise Rs 166.8 crore, making it another addition to an active primary market.